PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16266470-0	2005	[Association of polymorphism in alpha-adducin gene with antihypertensive effect of Hydrochlorothiazide].	Hydrochlorothiazide	83-102	adducin 1	Homo sapiens	32-45	
16266470-1	2005	OBJECTIVE: To explore the association between G614T single nuclear polymorphism (SNP) of the alpha-adducin gene and the antihypertensive effect of hydrochlorothiazide (HCTZ) in essential hypertensive (EH) patients.	Hydrochlorothiazide	147-166	adducin 1	Homo sapiens	93-106	
16266470-1	2005	OBJECTIVE: To explore the association between G614T single nuclear polymorphism (SNP) of the alpha-adducin gene and the antihypertensive effect of hydrochlorothiazide (HCTZ) in essential hypertensive (EH) patients.	Hydrochlorothiazide	168-172	adducin 1	Homo sapiens	93-106	
16266470-5	2005	RESULTS: After 6 weeks of HCTZ treatment, the decreases in DBP and MAP of patients carrying 614T allele of alpha-adducin were significantly greater than that of those carrying GG homozygotes (P < 0.05).	Hydrochlorothiazide	26-30	adducin 1	Homo sapiens	107-120	
16266470-9	2005	CONCLUSION: The present study suggests that the alpha-adducin G614T polymorphism is associated with the antihypertensive effect of HCTZ, which is more effective in patients with TT genotype.	Hydrochlorothiazide	131-135	adducin 1	Homo sapiens	48-61